Effects of sevoflurane targeting FOXO3 through miR-21-5p on cervical cancer
Objective To explore the molecular mechanisms by which sevoflurane(Sevo)affects cervical cancer.Methods HeLa cells were divided into NC group(no treatment),mimics-NC group(50 nmol L-1 mimic negative control transfection for 24 h),miR-21-5p mimics group(50 nmol·L-1 miR-21-5p mimic transfection for 24 h),inhibitor-NC group(50 nmol·L-1 miR-21-5p inhibitor negative control transfection for 24 h),miR-21-5p inhibitor group(50 nmol·L-1 miR-21-5p inhibitor transfection for 24 h),Sevo group(4%sevoflurane treatment for 24 h),Sevo combined miR-21-5p inhibitor group(miR-21-5p inhibitor was transfected for 24 h and then treated with 4%Sevo for 24 h).The effects of Sevo on cell proliferation,migration and invasion were detected by 5-ethynyl-2'-deoxyuridine(Edu)assay,cell scratch assay and transwell assay;Western blotting and vacuolar protein sorting 35(VPS35)were used to detect autophagy-related protein phosphatase and tensin homolog(PTEN);immunocytochemistry(ICC)assay was used to detect forkhead box O3(FOXO3).Results The positive expression proportions of FOXO3 in the mimics-NC group,miR-21-5p mimics group,inhibitor-NC group and miR-21-5p inhibitor group were(27.45±3.66)%,(14.01±1.76)%,(30.18±4.15)%and(72.47±9.42)%,respectively.The difference between the inhibitor group was statistically significant(P<0.01).The proliferation rates of NC group,Sevo group and Sevo combined miR-21-5p inhibitor group were(65.73±8.09)%,(89.04±9.65)%,(62.85±7.18)%;the migration rates were(31.39±3.95)%,(54.27±6.46)%,(40.10±5.42)%;the number of invasions were 157.45±19.22,225.73±26.44,124.46±15.18,respectively;the VPS35 protein expression levels were 1.00±0.15,2.67±0.34,1.28±0.17;PTEN protein expression levels were 1.00±0.12,0.63±0.09,2.49±0.33,the difference between the NC group and the Sevo group,between the Sevo group and the Sevo combined miR-21-5p inhibitor group was statistically significant(P<0.05,P<0.01,P<0.001).Conclusion Sevoflurane promotes the proliferation,migration,and invasion of cervical cancer cells through miR-21-5p targeting FOXO3.